References
- Evans AS, Niederman JC, McCollum RW. Infectious mononucleosis: role of EB virus. N Engl J Med 1969: 280(2): 112
- Epstein MA, Achong BG. Various forms of Epstein-Barr virus infection in mail: established facts and a general concept. Lancet 1973: 2(833): 836–9
- Purtilo DT, Sakamoto K, Bamabei V, et al. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am J Med 1982: 73(1): 49–56
- Straus SE. Relapsing, recurrent and chronic infectious mononucleosis. In: Levine PH. Ablashi DV. Pearson GR. et al. eds. Epstein-Barr virus and associated diseases. Proceedings of the First International Symposium on Epstein-Barr Virus-Associated Malignant Diseases. Boston: Martinus Nijhoff. 1985: 18–33
- Behan PO, Behan WM, Bell EJ. The postviral fatigue Syndrome: an analysis of the findings in 50 cases. J Infect 1985: 10(3): 211–22
- Isaacs R. Chronic infectious mononucleosis. Blood 1948: 3: 858–61
- Bender CE. Recurrent mononucleosis. JAMA 1962: 182: 156–8
- Beard GM. Neurasthenia, or nervous exhaustion. Boston Med Surg J 1869: 3: 217–20
- Horwitz CA. Henle W, Henle G, et al. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med 1975: 58(3): 330–8
- Horwitz CA, Henle W, Henle G, et al. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985: 151(6): 1150–3
- Henle W, Henle G, Andersson J, et al. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Ban- virus Infection. Proc Natl Acad Sci USA 1987: 84(2): 570–4
- Miller G, Grogan E, Duncan K, et al. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. N Engl J Med 1985: 312(12): 750–5
- Schooley RT, Carey RW, Miller G, et al. Chronic Epstein-Barr virus infection associated with fever and intestinal pneumonitis: clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med 1986: 104(5): 636–43
- Tobi M, Morag A. Ravid Z, et al. Prolonged atypical illness associated.with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982: 1 (8263): 61–4
- DuBois RE, Seeley JK, Bras I, et al. Chronic mononucleosis syndrome. South Med J 1984: 77(11): 1376–82
- Jones JF, Ray CG, Minnich LL, et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985: 102(1): 1–7
- Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985: 102(1): 7–16
- Kibler R, Lucas DO, Hicks MJ, et al. Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 1985: 5(1): 46–54
- Tobi M, Straus SE. Chronic Epstein-Barr virus disease: a workshop held by the National Institute of Alleigy and Infectious Diseases. Ann Intern Med 1985: 103(6 Pt 1): 951–3
- Henderson DA, Shelekov A. Epidemic neuromyasthenia: a clinical syndrome? N Engl J Med 1959: 260(15)757–64
- Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus. HBLV, in patients with lymphoproliferative disorders. Science 1986: 234(4776): 596–601